Carried to the infection inside white cells and released there
Tissue levels persist for days after the last dose
Manufactured in a dedicated sterile facility with terminal sterility assurance
Every batch tested for sterility, pyrogens and particulate matter before release
Indications of Azipril-500
Community-acquired pneumonia
Atypical pneumonia
Enteric fever
Respiratory tract infection
How Azipril-500 works
Azithromycin blocks bacterial protein synthesis and concentrates inside white blood cells, which carry it to the site of infection and release it there. Tissue levels therefore stay high for days after the last dose, and it covers the atypical organisms that beta-lactams miss entirely.
Why ChooseAzipril-500?
Manufactured at a WHO-GMP certified facility in a dedicated injectable block, under GLP, ISO and GMP norms. With an injectable the only thing that truly matters is what a patient will not see: sterility, absence of pyrogens, and freedom from particulate matter. Every batch is tested for all three before release, alongside assay and stability. Vials, stoppers and seals are sourced from approved vendors and checked at intake. Offered to PCD franchise partners and to institutional buyers on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Azipril-500
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Azipril-500?
Azithromycin 500 mg.
How is sterility assured?
Manufacturing is carried out in a dedicated injectable block under WHO-GMP norms, and every batch is tested for sterility, pyrogens and particulate matter before it is released.
Do you supply to hospitals and institutions?
Yes. We supply PCD franchise partners as well as hospitals and institutional buyers. Contact our team for rate contracts and supply terms.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.